Investigational Site Number : 0320005

CABA, Buenos Aires F.D. C1425ASG

0 studies enrolling now · 2 studies all time

What they study most

Dermatitis Atopic, Plasma Cell Myeloma Recurrent

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids — Completed
• SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM — Running, not enrolling